Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 3857-3865

  Shirinbak, Soheila ^a   Taher, Yousef A ^b   Maazi, Hadi ^a   Gras, Renée ^a   Van Esch, Betty C A M ^b   Henricks, Paul A J ^b   Samsom, Janneke N ^c   Verbeek, J Sjef ^d   Lambrecht, Bart N ^e   Van Oosterhout, Antoon J M ^a   Nawijn, Martijn C ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD16 ANTIGEN; FC RECEPTOR IIB; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; CYTOKINE; FC RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; B LYMPHOCYTE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; DESENSITIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PNEUMONIA;

ALLERGENS; ANIMALS; B-LYMPHOCYTES; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE TOLERANCE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PNEUMONIA; RECEPTORS, IGG; TH2 CELLS;

EID: 77958115117     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903909     Document Type: Review

References (53)

1. James, L. K., and S. R. Durham. 2008. Update on mechanisms of allergen injection immunotherapy. Clin. Exp. Allergy 38:1074-1088.
2. Bousquet, J. 1999. Specific immunotherapy in asthma. Allergy 54 (Suppl. 56):37-38.
3. Till, S. J., J. N. Francis, K. Nouri-Aria, and S. R. Durham. 2004. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113:1025-1034, quiz 1035.
4. Larché, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6:761-771.
5. Akdis, M., K. Blaser, and C. A. Akdis. 2005. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J. Allergy Clin. Immunol. 116:961-968, quiz 969.
6. Djurup, R., and H. J. Malling. 1987. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin. Allergy 17:459-468.
7. Ewan, P. W., J. Deighton, A. B. Wilson, and P. J. Lachmann. 1993. Venomspecific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin. Exp. Allergy 23:647-660.
8. Lichtenstein, L. M., N. A. Holtzman, and L. S. Burnett. 1968. A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J. Immunol. 101:317-324.
9. García, B. E., M. L. Sanz, J. J. Gato, J. Fernández, and A. Oehling. 1993. IgG4 blocking effect on the release of antigen-specific histamine. J. Investig. Allergol. Clin. Immunol. 3:26-33.
10. Daëron, M., O. Malbec, S. Latour, M. Arock, and W. H. Fridman. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95:577-585.
11. Coggeshall, K. M. 1998. Inhibitory signaling by B cell Fc gamma RIIb. Curr. Opin. Immunol. 10:306-312.
12. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-290.
13. Anderson, C. F., J. S. Gerber, and D. M. Mosser. 2002. Modulating macrophage function with IgG immune complexes. J. Endotoxin Res. 8:477-481.
14. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188:217-222.
15. Pilette, C., K. T. Nouri-Aria, M. R. Jacobson, L. K. Wilcock, B. Detry, S. M. Walker, J. N. Francis, and S. R. Durham. 2007. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J. Immunol. 178:4658-4666.
16. Jutel, M., M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser, and C. A. Akdis. 2003. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33:1205-1214.
17. Lack, G., H. S. Nelson, D. Amran, A. Oshiba, T. Jung, K. L. Bradley, P. C. Giclas, and E. W. Gelfand. 1997. Rush immunotherapy results in allergenspecific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J. Allergy Clin. Immunol. 99:530-538.
18. Van Oosterhout, A. J., B. Van Esch, G. Hofman, C. L. Hofstra, I. Van Ark, F. P. Nijkamp, M. L. Kapsenberg, H. F. Savelkoul, and F. R. Weller. 1998. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 19:622-628. (Pubitemid 128354244)
19. Vissers, J. L., B. C. van Esch, G. A. Hofman, M. L. Kapsenberg, F. R. Weller, and A. J. van Oosterhout. 2004. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J. Allergy Clin. Immunol. 113:1204-1210.
20. Schmitz, N., K. Dietmeier, M. Bauer, M. Maudrich, S. Utzinger, S. Muntwiler, P. Saudan, and M. F. Bachmann. 2009. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. J. Exp. Med. 206:1941-1955.
21. Korsgren, M., J. S. Erjefält, O. Korsgren, F. Sundler, and C. G. Persson. 1997. Allergic eosinophil-rich inflammation develops in lungs and airways of B celldeficient mice. J. Exp. Med. 185:885-892.
22. MacLean, J. A., A. Sauty, A. D. Luster, J. M. Drazen, and G. T. De Sanctis. 1999. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am. J. Respir. Cell Mol. Biol. 20:379-387.
23. Hamelmann, E., K. Tadeda, A. Oshiba, and E. W. Gelfand. 1999. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness-a murine model. Allergy 54:297-305.
24. Taher, Y. A., B. J. Piavaux, R. Gras, B. C. van Esch, G. A. Hofman, N. Bloksma, P. A. Henricks, and A. J. van Oosterhout. 2008. Indoleamine 2, 3-dioxygenasedependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J. Allergy Clin. Immunol. 121:983-991.e2.
25. Janssen, E. M., M. H. Wauben, E. H. Jonker, G. Hofman, W. Van Eden, F. P. Nijkamp, and A. J. Van Oosterhout. 1999. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 21:21-29.
26. Taher, Y. A., B. C. van Esch, G. A. Hofman, P. A. Henricks, and A. J. van Oosterhout. 2008. 1alpha, 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J. Immunol. 180:5211-5221.
27. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224:201-214.
28. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915-922.
29. Macpherson, A. J., A. Lamarre, K. McCoy, G. R. Harriman, B. Odermatt, G. Dougan, H. Hengartner, and R. M. Zinkernagel. 2001. IgA production without mu or delta chain expression in developing B cells. Nat. Immunol. 2:625-631.
30. Hamelmann, E., K. Takeda, J. Schwarze, A. T. Vella, C. G. Irvin, and E. W. Gelfand. 1999. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am. J. Respir. Cell Mol. Biol. 21:480-489.
31. Schwarze, J., G. Cieslewicz, A. Joetham, L. K. Sun, W. N. Sun, T. W. Chang, E. Hamelmann, and E. W. Gelfand. 1998. Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am. J. Respir. Crit. Care Med. 158:519-525. (Pubitemid 28378182)
32. Johansen, F. E., M. Pekna, I. N. Norderhaug, B. Haneberg, M. A. Hietala, P. Krajci, C. Betsholtz, and P. Brandtzaeg. 1999. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 190:915-922.
33. -/- mice abrogates the development of allergic lung inflammation. J. Immunol. 175:1276-1285.
34. Niu, N., M. K. Le Goff, F. Li, M. Rahman, R. J. Homer, and L. Cohn. 2007. A novel pathway that regulates inflammatory disease in the respiratory tract. J. Immunol. 178:3846-3855.
35. Schramm, C. M., L. Puddington, C. Wu, L. Guernsey, M. Gharaee-Kermani, S. H. Phan, and R. S. Thrall. 2004. Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease. Am. J. Pathol. 164:295-304.
36. Van Hove, C. L., T. Maes, G. F. Joos, and K. G. Tournoy. 2007. Prolonged inhaled allergen exposure can induce persistent tolerance. Am. J. Respir. Cell Mol. Biol. 36:573-584.
37. Durham, S. R., V. A. Varney, M. Gaga, M. R. Jacobson, E. M. Varga, A. J. Frew, and A. B. Kay. 1999. Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin. Exp. Allergy 29:1490-1496.
38. Fling, J. A., M. E. Ruff, W. A. Parker, B. A. Whisman, M. E. Martin, R. B. Moss, and M. J. Reid. 1989. Suppression of the late cutaneous response by immunotherapy. J. Allergy Clin. Immunol. 83:101-109.
39. Varney, V. A., Q. A. Hamid, M. Gaga, S. Ying, M. Jacobson, A. J. Frew, A. B. Kay, and S. R. Durham. 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92:644-651.
40. Iliopoulos, O., D. Proud, N. F. Adkinson, Jr., P. S. Creticos, P. S. Norman, A. Kagey-Sobotka, L. M. Lichtenstein, and R. M. Naclerio. 1991. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J. Allergy Clin. Immunol. 87:855-866.
41. Flicker, S., and R. Valenta. 2003. Renaissance of the blocking antibody concept in type I allergy. Int. Arch. Allergy Immunol. 132:13-24.
42. Müller, U., A. Helbling, and M. Bischof. 1989. Predictive value of venomspecific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 44:412-418.
43. Bruhns, P., S. Frémont, and M. Daëron. 2005. Regulation of allergy by Fc receptors. Curr. Opin. Immunol. 17:662-669.
44. Kraft, S., and J. P. Kinet. 2007. New developments in FcepsilonRI regulation, function and inhibition. Nat. Rev. Immunol. 7:365-378.
45. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454:445-454.
46. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, and J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 368:70-73.
47. Daëron, M., O. Malbec, S. Latour, E. Espinosa, P. Pina, and W. H. Fridman. 1995. Regulation of tyrosine-containing activation motif-dependent cell signalling by Fc gamma RII. Immunol. Lett. 44:119-123.
48. Tsitoura, D. C., R. L. Blumenthal, G. Berry, R. H. Dekruyff, and D. T. Umetsu. 2000. Mechanisms preventing allergen-induced airways hyperreactivity: role of tolerance and immune deviation. J. Allergy Clin. Immunol. 106:239-246.
49. Tsitoura, D. C., V. P. Yeung, R. H. DeKruyff, and D. T. Umetsu. 2002. Critical role of B cells in the development of T cell tolerance to aeroallergens. Int. Immunol. 14:659-667.
50. Vella, A. T., M. T. Scherer, L. Schultz, J. W. Kappler, and P. Marrack. 1996. B cells are not essential for peripheral T-cell tolerance. Proc. Natl. Acad. Sci. USA 93:951-955.
51. Samsom, J. N., L. A. van Berkel, J. M. van Helvoort, W. W. Unger, W. Jansen, T. Thepen, R. E. Mebius, S. S. Verbeek, and G. Kraal. 2005. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J. Immunol. 174:5279-5287.
52. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4:762-774.
53. Campbell, J. D., K. F. Buckland, S. J. McMillan, J. Kearley, W. L. Oldfield, L. J. Stern, H. Grönlund, M. van Hage, C. J. Reynolds, R. J. Boyton, et al. 2009. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 206:1535-1547.